Dr. Ethan Russo: Cannabis & Endocannabinoid System Breakthroughs | CannabizMD 2021 Keynote

Описание: This is the keynote presentation from the CannabizMD 2021 Cannabis Science and Policy Forum, featuring Dr. Ethan Russo, one of the world's leading authorities on cannabis medicine.

About This Keynote:
Dr. Russo presents groundbreaking research on two critical conditions reshaping cannabis therapeutics:
Cannabinoid Hyperemesis Syndrome (CHS) - The largest genetic study to date, examining 585 respondents and identifying five statistically significant genetic mutations predicting susceptibility to this mysterious condition affecting chronic cannabis users.

Fibromyalgia Research - Investigating whether autoantibodies attacking cannabinoid receptors could explain fibromyalgia, potentially providing the first laboratory test for a condition affecting 10 million Americans.

About Dr. Russo:
Board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science. Former Senior Medical Advisor to GW Pharmaceuticals for clinical trials leading to Sativex and Epidiolex. Author of the landmark paper "Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects." 30+ years of cannabis research with 50+ peer-reviewed publications.

Learn how genetics predict adverse cannabis reactions, the Clinical Endocannabinoid Deficiency theory, and evidence-based approaches to cannabis therapeutics from one of the field's pioneering researchers.

About CannabizMD:
CannabizMD is a leading provider of evidence-based cannabis science and policy education, including workforce development programs, training for industry professionals, and education for healthcare providers. Through partnerships with world-renowned experts like Dr. Russo, CannabizMD offers professional development programs that advance scientific understanding of cannabis therapeutics and state and federal regulations.